HOPE ERNEST G has a total of 12 patent applications. Its first patent ever was published in 2000. It filed its patents most often in United States, Australia and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and chemical engineering are BOEHRINGER INGELHEIM VETMEDICA GMBH, PEROSPHERE INC and KECK GRADUATE INST OF APPLIED LIFE SCIENCES.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 3 | |
#2 | Australia | 2 | |
#3 | Canada | 2 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | WIPO (World Intellectual Property Organization) | 2 | |
#6 | China | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Chemical engineering | |
#4 | Machines |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Chemical or physical laboratory devices | |
#4 | Microbiology | |
#5 | Unspecified technologies | |
#6 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Hope Ernest G | 11 |
Publication | Filing date | Title |
---|---|---|
CN101395327A | Prevalidated, modular medicament manufacturing practice-compliant facility | |
AU2005239674A1 | Anti-angiogenic cellular agent for cancer therapy | |
AU2425801A | Anti-angiogenic cellular agent for cancer therapy |